We are live on
!
Find out more
AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$790M
1-Year Est. Return
223.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+223.66%
3 Year Est. Return
+485.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$790M
AUM Growth
-$75.1M
(-8.7%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-8.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$59.8M |
| 2 |
Kymera Therapeutics
KYMR
|
+$6.48M |
| 3 |
GBIO
Generation Bio
GBIO
|
+$4.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kymera Therapeutics
KYMR
$9.38B
| $381M | 48.26% |
4,578,008
-81,866
| -2% | -$6.48M |
|
2
Dyne Therapeutics
DYN
$3.76B
| $166M | 20.95% |
9,130,465
| – | – |
|
|
SION
3
Sionna Therapeutics
SION
$2.04B
| $120M | 15.2% |
2,995,602
| – | – |
|
4
Disc Medicine
IRON
$2.81B
| $96.8M | 12.25% |
1,513,875
| – | – |
|
5
Q32 Bio
QTTB
$258M
| $13.4M | 1.7% |
2,092,106
| – | – |
|
6
Korro Bio
KRRO
$177M
| $12.9M | 1.63% |
1,137,149
| – | – |
|
|
DAWN
7
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-6,412,560
| Closed | -$59.8M |
|
|
GBIO
8
DELISTED
Generation Bio
GBIO
| – | – |
-827,946
| Closed | -$4.7M |
|
Similar funds
AWG
PWM
AT
MTWSIF
VH
M
AI
VCM